Developing an appropriate model for self-care of hypertensive patients in Iran

ARYA Atherosclerosis

Volumn 9, Issue 4, 2013, Pages 232-240

  Sadeghi, Masoumeh ^a   Shiri, Mansoor ^b   Roohafza, Hamidreza ^c   Rakhshani, Fatemeh ^d   Sepanlou, Sadaf ^e   Sarrafzadegan, Nizal ^c  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hypertension; Model; Self care

Indexed keywords

ADULT; ARTICLE; FEASIBILITY STUDY; FOLLOW UP; HEALTH CARE PERSONNEL; HUMAN; HYPERTENSION; INTERVIEW; IRAN; MODEL; PATIENT ATTITUDE; PILOT STUDY; SELF CARE;

EID: 84880396195     PISSN: 17353955     EISSN: 22516638     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Vasan RS, Sullivan LM, Wilson PW, Sempos CT, Sundstrom J, Kannel WB, et al. Relative importance of borderline and elevated levels of coronary heart disease risk factors. Ann Intern Med 2005; 142(6): 393-402.
2. Sarrafzadegan N, Talaei M, Kelishadi R, Toghianifar N, Sadeghi M, Oveisgharan S, et al. The influence of gender and place of residence on cardiovascular diseases and their risk factors. The Isfahan cohort study. Saudi Med J 2012; 33(5): 533-40.
3. World Health Organization. The World Health Report 2002: Reducing Risks, Promoting Healthy Life. Geneva, Switzerland: World Health Organization; 2002.
4. Sarrafzadegan N, AminiNik S. Blood pressure pattern in urban and rural areas in Isfahan, Iran. J Hum Hypertens 1997; 11(7): 425-8.
5. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365(9455): 217-23.
6. Lenfant C, Chobanian AV, Jones DW, Roccella EJ. Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): resetting the hypertension sails. Hypertension 2003; 41(6): 1178-9.
7. Robitaille C, Dai S, Waters C, Loukine L, Bancej C, Quach S, et al. Diagnosed hypertension in Canada: incidence, prevalence and associated mortality. CMAJ 2012; 184(1): E49-E56.
8. Wang Y, Wang QJ. The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem. Arch Intern Med 2004; 164(19): 2126-34.
9. Gus I, Harzheim E, Zaslavsky C, Medina C, Gus M. Prevalence, awareness, and control of systemic arterial hypertension in the state of Rio Grande do Sul. Arq Bras Cardiol 2004; 83(5): 429-33.
10. Ulasi II, Ijoma CK, Onwubere BJ, Arodiwe E, Onodugo O, Okafor C. High prevalence and low awareness of hypertension in a market population in enugu, Nigeria. Int J Hypertens 2011; 2011: 869675.
11. Saeed AA, Al-Hamdan NA, Bahnassy AA, Abdalla AM, Abbas MA, Abuzaid LZ. Prevalence, Awareness, Treatment, and Control of Hypertension among Saudi Adult Population: A National Survey. Int J Hypertens 2011; 2011: 174135.
12. Dorobantu M, Darabont RO, Badila E, Ghiorghe S. Prevalence, Awareness, Treatment, and Control of Hypertension in Romania: Results of the SEPHAR Study. Int J Hypertens 2010; 2010: 970694.
13. Cai L, Liu A, Zhang L, Li S, Wang P. Prevalence, awareness, treatment, and control of hypertension among adults in Beijing, China. Clin Exp Hypertens 2012; 34(1): 45-52.
14. Kaur P, Rao SR, Radhakrishnan E, Rajasekar D, Gupte MD. Prevalence, awareness, treatment, control and risk factors for hypertension in a rural population in South India. Int J Public Health 2012; 57(1): 87-94.
15. Pereira M, Lunet N, Azevedo A, Barros H. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens 2009; 27(5): 963-75.
16. NHS. Supporting people with long term conditions to Self Care A guide to developing local strategies and good practice [Online]. 2006; Available from: URL: http://selfmanagementsupport.health.org.uk/media_ manager/public/179/SMS_resourcecentre_ publications/Self%20care%20-%20a%20guide%20to%20developing%20local%20 strategies%20and%20good%20practice.pdf/
17. DAFNE. Type 1 diabetes [Online]. 2013; Available from: URL: http://www.dafne.uk.com/
18. Klymko KW, Artinian NT, Price JE, Abele C, Washington OG. Self-care production experiences in elderly African Americans with hypertension and cognitive difficulty. J Am Acad Nurse Pract 2011; 23(4): 200-8.
19. Warren-Findlow J, Seymour RB, Brunner Huber LR. The association between self-efficacy and hypertension self-care activities among African American adults. J Community Health 2012; 37(1): 15-24.
20. Gohar F, Greenfield SM, Beevers DG, Lip GY, Jolly K. Self-care and adherence to medication: a survey in the hypertension outpatient clinic. BMC Complement Altern Med 2008; 8: 4.
21. Padfield PL. The case for home monitoring in hypertension. BMC Med 2010; 8: 55.
22. Carter BL, Rogers M, Daly J, Zheng S, James PA. The potency of team-based care interventions for hypertension: a meta-analysis. Arch Intern Med 2009; 169(19): 1748-55.
23. Victor RG, Ravenell JE, Freeman A, Leonard D, Bhat DG, Shafiq M, et al. Effectiveness of a barberbased intervention for improving hypertension control in black men: the BARBER-1 study: a cluster randomized trial. Arch Intern Med 2011; 171(4): 342-50.
24. Carter BL, Ardery G, Dawson JD, James PA, Bergus GR, Doucette WR, et al. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med 2009; 169(21): 1996-2002.
25. Woodward A, Wallymahmed M, Wilding J, Gill G. Successful cardiovascular risk reduction in Type 2 diabetes by nurse-led care using an open clinical algorithm. Diabet Med 2006; 23(7): 780-7.
26. Cappuccio FP, Kerry SM, Forbes L, Donald A. Blood pressure control by home monitoring: metaanalysis of randomised trials. BMJ. 2004; 329(7458): 145.
27. Glynn LG, Murphy AW, Smith SM, Schroeder K, Fahey T. Self-monitoring and other nonpharmacological interventions to improve the management of hypertension in primary care: a systematic review. Br J Gen Pract 2010; 60(581): e476-e488.
28. McManus RJ, Mant J, Roalfe A, Oakes RA, Bryan S, Pattison HM, et al. Targets and self monitoring in hypertension: randomised controlled trial and cost effectiveness analysis. BMJ 2005; 331(7515): 493.
29. Appel LJ, Champagne CM, Harsha DW, Cooper LS, Obarzanek E, Elmer PJ, et al. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA 2003; 289(16): 2083-93.
30. Verberk WJ, Kroon AA, Lenders JW, Kessels AG, van Montfrans GA, Smit AJ, et al. Selfmeasurement of blood pressure at home reduces the need for antihypertensive drugs: a randomized, controlled trial. Hypertension 2007; 50(6): 1019-25.
31. Green B, Anderson M, Catz S, Ralston J. PS2-14: Self-Reported Use of Home Blood Pressure Monitoring Does Not Predict Improved Hypertension Control. Clin Med Res 2011; 9(3-4): 152-3.
32. Reed SD, Li Y, Oddone EZ, Neary AM, Orr MM, Grubber JM, et al. Economic evaluation of home blood pressure monitoring with or without telephonic behavioral self-management in patients with hypertension. Am J Hypertens 2010; 23(2): 142-8.
33. Becker MH. The health belief model and personal health behaviour. Health Educ Monogr 1974; 2(4): 324-508.
34. Leiva A, Fajo M, Escriche L, Audera FJ, Lopez S, Martin MC, et al. Efficacy of a brief multifactorial adherence-based intervention on reducing the blood pressure of patients with poor adherence: protocol for a randomized clinical trial. BMC Cardiovasc Disord 2010; 10: 44.
35. Thiboutot J, Stuckey H, Binette A, Kephart D, Curry W, Falkner B, et al. A web-based patient activation intervention to improve hypertension care: study design and baseline characteristics in the web hypertension study. Contemp Clin Trials 2010; 31(6): 634-46.
36. McManus RJ, Bray EP, Mant J, Holder R, Greenfield S, Bryan S, et al. Protocol for a randomised controlled trial of telemonitoring and self-management in the control of hypertension: telemonitoring and self-management in hypertension. [ISRCTN17585681]. BMC Cardiovasc Disord 2009; 9: 6.
37. Sadeghi M, Ramezani J, Sanei H, Rabeiee K, Gharipoor M, Toghianifar N. Adherence to evidence-based therapies and modifiable risk factors in patients with coronary artery disease-the hlcp project. ARYA Atheroscler 2006; 2(3): 147-51.
38. Talaei M, Sadeghi M, Marshall T, Thomas GN, Kabiri P, Hoseini S, et al. Impact of metabolic syndrome on ischemic heart disease-a prospective cohort study in an Iranian adult population: Isfahan Cohort Study. Nutr Metab Cardiovasc Dis 2012; 22(5): 434-41.
39. Bozorgmanesh M, Hadaegh F, Sheikholeslami F, Azizi F. Cardiovascular risk and all-cause mortality attributable to diabetes: Tehran lipid and glucose study. J Endocrinol Invest 2012; 35(1): 14-20.
40. Esteghamati A, Meysamie A, Khalilzadeh O, Rashidi A, Haghazali M, Asgari F, et al. Third national Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia. BMC Public Health 2009; 9: 167.
41. Khosravi A, Mehr GK, Kelishadi R, Shirani S, Gharipour M, Tavassoli A, et al. The impact of a 6-year comprehensive community trial on the awareness, treatment and control rates of hypertension in Iran: experiences from the Isfahan healthy heart program. BMC Cardiovasc Disord 2010; 10: 61.